Evidence map›Paper›PMID 41973479›Full record

ArticleJournal of chemical information and modeling2026

Biophysical Modeling Elucidates Mechanistic Principles for Rational Molecular Glue Design.

Seok Joo Chae, Jonathon DeBonis, Joseph Quinlan, Ryan Richards, Junmin Wang, Gustavo Gutierrez, Jonathan Tart, Maxime Couturier, Sergio Martinez Cuesta, Meizhong Jin and 1 more

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Seok Joo ChaeDepartment of Bioengineering, Rice University, Houston, Texas 77005-1892, United States.
Jonathon DeBonisDepartment of Bioengineering, Rice University, Houston, Texas 77005-1892, United States.ORCID 0009-0004-8965-383X
Joseph QuinlanDepartment of Bioengineering, Rice University, Houston, Texas 77005-1892, United States.ORCID 0000-0002-0692-9502
Ryan RichardsOncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.
Junmin WangDiscovery Sciences, AstraZeneca, Waltham, Massachusetts 02451, United States.
Gustavo GutierrezDiscovery Sciences, AstraZeneca, Cambridge CB2 0AA, U.K.
Jonathan TartDiscovery Sciences, AstraZeneca, Cambridge CB2 0AA, U.K.
Maxime CouturierDiscovery Sciences, AstraZeneca, Cambridge CB2 0AA, U.K.ORCID 0009-0008-3031-3178
Sergio Martinez CuestaDiscovery Sciences, AstraZeneca, Cambridge CB2 0AA, U.K.
Meizhong JinOncology R&D, AstraZeneca, Waltham, Massachusetts 02451, United States.
Oleg A IgoshinDepartment of Bioengineering, Rice University, Houston, Texas 77005-1892, United States.ORCID 0000-0002-1449-4772

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molecular glues are small molecules that offer a powerful strategy to target previously "undruggable" proteins of interest (POI) by enhancing their interactions with other proteins (effectors). Depending on the nature of the effectors, molecular glues can induce stabilizing sequestration or degradation of the POI. However, their rational design has been hindered by a poor understanding of how kinetic parameters impact their performance. To address this, we developed a unified mathematical framework that accurately represents the dynamics of both glue degraders and stabilizers in both in vitro and cellular contexts. By analyzing our model, we determined the effects of varying specific kinetic parameters on the cellular-level performance of molecular glues. Our model suggests that the binding affinity of the ternary complex is the key determinant of performance across both modalities, provided that the initial component concentrations and degradation rate constants are fixed. Furthermore, we demonstrated that degrader performance is ultimately limited by its catalytic efficiency and the target protein's natural half-life. We also identified distinct roles for effector abundance, showing that the relative concentrations of the effector and POI are critical for stabilizers but less so for degraders. This quantitative framework provides mechanistic principles for the rational design and optimization of molecular glues.

Indexed as

Drug DesignModels, MolecularProteinsKineticsProteins

Identifiers

PMID41973479
PMCPMC13126642

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.